These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6463283)

  • 21. Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dog.
    Fried M; Beglinger C; Koehler E; Whitehouse I; Varga L; Gyr K
    Regul Pept; 1984 Mar; 8(2):117-22. PubMed ID: 6729149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of cholecystokinin and its antagonist proglumide on macronutrient selection in European sea bass Dicentrarchus labrax, L.
    Rubio VC; Sánchez-Vázquez FJ; Madrid JA
    Physiol Behav; 2008 Mar; 93(4-5):862-9. PubMed ID: 18207473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin-8 and proglumide modulation of electrically elicited eating.
    Schneider LH
    Prog Clin Biol Res; 1985; 192():123-30. PubMed ID: 4080705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system.
    Chiodo LA; Bunney BS
    Science; 1983 Mar; 219(4591):1449-51. PubMed ID: 6828873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
    Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
    Poston GJ; MacLellan DG; Hashimoto T; Upp JR; Townsend CM; Thompson JC
    Surg Gynecol Obstet; 1990 Mar; 170(3):217-22. PubMed ID: 2305348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.
    Bunney BS; Chiodo LA; Freeman AS
    Ann N Y Acad Sci; 1985; 448():345-51. PubMed ID: 2862828
    [No Abstract]   [Full Text] [Related]  

  • 28. Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine.
    Pfaus JG; Phillips AG
    Eur J Pharmacol; 1987 Sep; 141(3):331-8. PubMed ID: 3666030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma concentrations of cholecystokinin octapeptide and food intake in male rats treated with cholecystokinin octapeptide.
    Lindén A; Uvnäs-Moberg K; Forsberg G; Bednar I; Södersten P
    J Endocrinol; 1989 Apr; 121(1):59-65. PubMed ID: 2565947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
    Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic proglumide increases [3H]spiperone binding in the rat brain.
    Bean AJ; Baldy WJ; Martin GE
    Eur J Pharmacol; 1985 Oct; 117(1):97-101. PubMed ID: 4085545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cholecystokinin receptor antagonist CR1409 increases plasma cholecystokinin in rats.
    Jansen JB; de Jong AJ; Lamers CB
    Regul Pept; 1989 Feb; 24(2):209-13. PubMed ID: 2922496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous and exogenous cholecystokinin may reduce food intake by different mechanisms.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Aug; 253(2 Pt 2):R379-82. PubMed ID: 3618836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous cholecystokinin and intestinal satiety.
    Collins SM; Conover KL; Forsyth PA; Weingarten HP
    Am J Physiol; 1985 Dec; 249(6 Pt 2):R667-71. PubMed ID: 4073287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of phenylpropanolamine anorexia by proglumide in rats.
    Wellman PJ; Tow S
    Appetite; 1991 Apr; 16(2):121-7. PubMed ID: 2064390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cholecystokinin and of its antagonist, of atropine, and of food on the release of immunoglobulin A and immunoglobulin G specific antibodies in the rat intestine.
    Freier S; Eran M; Faber J
    Gastroenterology; 1987 Dec; 93(6):1242-6. PubMed ID: 3678742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of proglumide on morphine induced motility changes.
    Ben-Horin N; Ben-Horin E; Frenk H
    Psychopharmacology (Berl); 1984; 84(4):541-3. PubMed ID: 6441955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.